Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03017118 · ClinicalTrials.gov registry record · NA

Turmeric for Patients With Basal Joint Arthritis

A NA study of Thumb Osteoarthritis, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03017118 is a NA study of Thumb Osteoarthritis that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 111-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03017118, a NA study of Thumb Osteoarthritis, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Turmeric

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-08-09
Est. Completion 2028-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03017118

The ClinicalTrials.gov registry entry for NCT03017118 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (46% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03017118 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03017118 about?

NCT03017118 is a clinical study titled "Turmeric for Patients With Basal Joint Arthritis". The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthriti...

What is the current status of trial NCT03017118?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2017-08-09. Estimated completion is 2028-01.

What conditions does trial NCT03017118 study?

This clinical trial studies the following conditions: Thumb Osteoarthritis.

What interventions are being tested in trial NCT03017118?

The interventions under investigation include: Placebo (OTHER), Turmeric (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03017118?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03017118 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thumb Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.